Eli Lilly’s popular weight loss drug, Zepbound, may reduce the risk of developing Type 2 diabetes by 94% in obese and overweight adults with prediabetes, according to preliminary results from a ...
Eli Lilly's pill works in a similar way to Wegovy, Ozempic, and Novo Nordisk's diabetes pill Rybelsus, targeting a gut hormone called GLP-1 to suppress a person's appetite and regulate blood sugar.